99 related articles for article (PubMed ID: 21666141)
1. Locked nucleic acid probes for enhanced detection of FLT3 D835/I836, JAK2 V617F and NPM1 mutations.
Warshawsky I; Mularo F
J Clin Pathol; 2011 Oct; 64(10):905-10. PubMed ID: 21666141
[TBL] [Abstract][Full Text] [Related]
2. FLT3 mutations in myeloproliferative neoplasms: the Beaumont experience.
Williams L; Kelley HH; Meng X; Prada A; Crisan D
Diagn Mol Pathol; 2013 Sep; 22(3):156-60. PubMed ID: 23846442
[TBL] [Abstract][Full Text] [Related]
3. [A novel modi cation of real-time AS-qPCR by using locked nucleic acid-modified oligonucleotide probe as wild type allele amplification blockers for quantitative detection of the JAK2 V617F mutation].
Shao DH; Liang GW; He ML; Cao QY
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):421-5. PubMed ID: 23688754
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
Qiao M; Li WY; Sun AN; Chen SN; Liang JY; Ding ZX; Feng YF; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):679-83. PubMed ID: 22339826
[TBL] [Abstract][Full Text] [Related]
5. Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.
Rapado I; Albizua E; Ayala R; Hernández JA; Garcia-Alonso L; Grande S; Gallardo M; Gilsanz F; Martinez-Lopez J
Ann Hematol; 2008 Sep; 87(9):741-9. PubMed ID: 18575865
[TBL] [Abstract][Full Text] [Related]
6. Locked Nucleic Acid Probes (LNA) for Enhanced Detection of Low-Level, Clinically Significant Mutations.
Nafa K; Hameed M; Arcila ME
Methods Mol Biol; 2016; 1392():71-82. PubMed ID: 26843048
[TBL] [Abstract][Full Text] [Related]
7. Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia.
Chen W; Huang Q
Leuk Res; 2009 Nov; 33(11):e207-9. PubMed ID: 19540590
[No Abstract] [Full Text] [Related]
8. Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection.
Ohyashiki K; Hori K; Makino T; Ohyashiki JH
Cancer Genet Cytogenet; 2007 Nov; 179(1):19-24. PubMed ID: 17981210
[TBL] [Abstract][Full Text] [Related]
9. Polycythemia vera is not initiated by JAK2V617F mutation.
Nussenzveig RH; Swierczek SI; Jelinek J; Gaikwad A; Liu E; Verstovsek S; Prchal JF; Prchal JT
Exp Hematol; 2007 Jan; 35(1):32-8. PubMed ID: 17198871
[TBL] [Abstract][Full Text] [Related]
10. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.
Tan AY; Westerman DA; Dobrovic A
Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995
[TBL] [Abstract][Full Text] [Related]
11. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
Scholl S; Krause C; Loncarevic IF; Müller R; Kunert C; Wedding U; Sayer HG; Clement JH; Höffken K
J Lab Clin Med; 2005 Jun; 145(6):295-304. PubMed ID: 15976757
[TBL] [Abstract][Full Text] [Related]
12. Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay.
Murphy KM; Levis M; Hafez MJ; Geiger T; Cooper LC; Smith BD; Small D; Berg KD
J Mol Diagn; 2003 May; 5(2):96-102. PubMed ID: 12707374
[TBL] [Abstract][Full Text] [Related]
13. A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.
Roug AS; Nyvold CG; Juhl-Christensen C; Christensen M; Schnittger S; Hokland P
Eur J Haematol; 2011 Nov; 87(5):461-3. PubMed ID: 21689158
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood.
Stevenson WS; Hoyt R; Bell A; Guipponi M; Juneja S; Grigg AP; Curtis DJ; Scott HS; Szer J; Alexander WS; Tuckfield A; Roberts AW
Pathology; 2006 Aug; 38(4):336-42. PubMed ID: 16916724
[TBL] [Abstract][Full Text] [Related]
15. Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation.
Er TK; Lin SF; Chang JG; Hsieh LL; Lin SK; Wang LH; Lin CW; Chang CS; Liu TC
Clin Chim Acta; 2009 Oct; 408(1-2):39-44. PubMed ID: 19595684
[TBL] [Abstract][Full Text] [Related]
16. Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis.
Lay M; Mariappan R; Gotlib J; Dietz L; Sebastian S; Schrijver I; Zehnder JL
J Mol Diagn; 2006 Jul; 8(3):330-4. PubMed ID: 16825505
[TBL] [Abstract][Full Text] [Related]
17. [Detection of point mutation at second tyrosine kinase domain of FLT3 gene in acute myeloid leukemia].
Wang LH; Wang M; Zhou CL; Chen S; Zhang XW; Xing HY; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):335-8. PubMed ID: 16185475
[TBL] [Abstract][Full Text] [Related]
18. A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.
Poodt J; Fijnheer R; Walsh IB; Hermans MH
Hematol Oncol; 2006 Dec; 24(4):227-33. PubMed ID: 17006961
[TBL] [Abstract][Full Text] [Related]
19. Detection of nucleophosmin 1 mutations by quantitative real-time polymerase chain reaction versus capillary electrophoresis: a comparative study.
Barakat FH; Luthra R; Yin CC; Barkoh BA; Hai S; Jamil W; Bhakta YI; Chen S; Medeiros LJ; Zuo Z
Arch Pathol Lab Med; 2011 Aug; 135(8):994-1000. PubMed ID: 21809990
[TBL] [Abstract][Full Text] [Related]
20. A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).
Koren-Michowitz M; Shimoni A; Vivante A; Trakhtenbrot L; Rechavi G; Amariglio N; Loewenthal R; Nagler A; Cohen Y
Leuk Res; 2008 Mar; 32(3):421-7. PubMed ID: 17698191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
